This was the stock's second consecutive day of losses.

CME Group's strong performance and market-agnostic revenues support its resilience. Find out why CME stock is a Hold.

CME Group offers strong cash flow, market dominance, and a resilient business model. Click here to see why CME stock is a Buy ...

Yes, the Federal Reserve could cut interest rates later this year. Or, maybe it won't. In any case, a Fed reduction offers no ...

The stock's fall snapped a two-day winning streak.

You could benefit from refinancing now if you took out an auto loan while rates were at their peak or your financial health ...

Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

Appalaches Capital, an investment management firm, released its first quarter 2025 investor letter. A copy of the letter can ...

Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as ...

Valued at $101.7 billion by market cap, CME Group Inc. (CME) operates as the world’s leading derivatives marketplace. The ...

CME Group's CME +0.15% Get Free Report short percent of float has fallen 5.71% since its last report. The company recently ...

TradeStation lists CME’s XRP futures, offering cash-settled contracts amid rising demand for regulated crypto derivatives.